BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Villanacci V, Antonelli E, Geboes K, Casella G, Bassotti G. Histological healing in inflammatory bowel disease: A still unfulfilled promise. World J Gastroenterol 2013; 19(7): 968-978 [PMID: 23467585 DOI: 10.3748/wjg.v19.i7.968]
URL: https://www.wjgnet.com/1007-9327/full/v19/i7/968.htm
Number Citing Articles
1
Amirkaveh Mojtahed, Reena Khanna, William J. Sandborn, Geert R. DʼHaens, Brian G. Feagan, Lisa M. Shackelton, Kenneth A. Baker, Elena Dubcenco, Mark A. Valasek, Karel Geboes, Barrett G. Levesque. Assessment of Histologic Disease Activity in Crohnʼs DiseaseInflammatory Bowel Diseases 2014; 20(11): 2092 doi: 10.1097/MIB.0000000000000155
2
Rish K. Pai, Karel Geboes. Colitis2018; : 243 doi: 10.1007/978-3-319-89503-1_18
3
Angelo Viscido, Marco Valvano, Gianpiero Stefanelli, Annalisa Capannolo, Chiara Castellini, Eugenia Onori, Antonio Ciccone, Filippo Vernia, Giovanni Latella. Systematic review and meta-analysis: the advantage of endoscopic Mayo score 0 over 1 in patients with ulcerative colitisBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02157-5
4
V. Villanacci, G. Bassotti, C. Langner. Histological Remission in Inflammatory Bowel Disease: Where Are We, and Where Are We Going?Journal of Crohn's and Colitis 2015; 9(5): 428 doi: 10.1093/ecco-jcc/jjv043
5
Alissa Walsh, Andrey Kormilitzin, Christopher Hinds, Vanashree Sexton, Oliver Brain, Satish Keshav, Holm Uhlig, John Geddes, Guy Goodwin, Michele Peters, Gary Collins, Simon Travis. Defining Faecal Calprotectin Thresholds as a Surrogate for Endoscopic and Histological Disease Activity in Ulcerative Colitis—a Prospective AnalysisJournal of Crohn's and Colitis 2019; 13(4): 424 doi: 10.1093/ecco-jcc/jjy184
6
Vincenzo Villanacci, Luca Reggiani-Bonetti, Flavio Caprioli, Luca Saragoni, Tiziana Salviato, Claudia Mescoli, Gabriella Canavese, Stefania Manenti, Elisabetta Spada, Luigi Baron, Giuseppe Leoncini, Moris Cadei, Serena Battista, Alessandro Armuzzi. Histopathology of inflammatory bowel disease — Position statement of the Pathologists of the Italian Group for the Study of Inflammatory Bowel Disease (IG-IBD) and Italian Group of Gastrointestinal Pathologists (GIPAD-SIAPEC)Digestive and Liver Disease 2020; 52(3): 262 doi: 10.1016/j.dld.2019.11.005
7
Murat Cayci, Erdal Birol Bostanci, Nesrin Turhan, Kerem Karaman, Tahsin Dalgic, Ilter Ozer, Metin Ercan, Murat Ulas, Musa Akoglu. The analysis of clinico-pathologic characteristics in patients who underwent surgery due to stricturing and non-perineal fistulizing forms of Crohn's disease: A retrospective cohort studyInternational Journal of Surgery 2015; 15: 49 doi: 10.1016/j.ijsu.2015.01.029
8
Giuseppe Frieri, Brigida Galletti, Mirko Di Ruscio, Rachele Tittoni, Annalisa Capannolo, Donatella Serva, Giovanni Latella, Laura Sollima, Pietro Leocata, Stefano Necozione, Rosamarie Frieri, Angelo Viscido. The prognostic value of histology in ulcerative colitis in clinical remission with mesalazineTherapeutic Advances in Gastroenterology 2017; 10(10): 749 doi: 10.1177/1756283X17722926
9
Mao Matsubayashi, Taku Kobayashi, Shinji Okabayashi, Masaru Nakano, Shintaro Sagami, Ryo Ozaki, Hiroki Kiyohara, Hiromu Morikubo, Kunio Asonuma, Yusuke Miyatani, Shin Maeda, Toshifumi Hibi. Determining the usefulness of Capsule Scoring of Ulcerative Colitis in predicting relapse of inactive ulcerative colitisJournal of Gastroenterology and Hepatology 2021; 36(4): 943 doi: 10.1111/jgh.15220
10
Robert V Bryant, Daniel C Burger, Joseph Delo, Alissa J Walsh, Sally Thomas, Axel von Herbay, Otto C Buchel, Lydia White, Oliver Brain, Satish Keshav, Bryan F Warren, Simon P L Travis. Beyond endoscopic mucosal healing in UC: histological remission better predicts corticosteroid use and hospitalisation over 6 years of follow-upGut 2016; 65(3): 408 doi: 10.1136/gutjnl-2015-309598
11
Hwajeong Lee, Maria Westerhoff, Bo Shen, Xiuli Liu. Clinical Aspects of Idiopathic Inflammatory Bowel Disease: A Review for PathologistsArchives of Pathology & Laboratory Medicine 2016; 140(5): 413 doi: 10.5858/arpa.2015-0305-RA
12
Erica E. Alexeev, Alexander S. Dowdell, Morkos A. Henen, Jordi M. Lanis, J. Scott Lee, Ian M. Cartwright, Rachel E. M. Schaefer, Alfredo Ornelas, Joseph C. Onyiah, Beat Vögeli, Sean P. Colgan. Microbial‐derived indoles inhibit neutrophil myeloperoxidase to diminish bystander tissue damageThe FASEB Journal 2021; 35(5) doi: 10.1096/fj.202100027R
13
Antonio Tursi, Walter Elisei, Marcello Picchio, Antonio Penna, Piera Giuseppina Lecca, Giacomo Forti, GianMarco Giorgetti, Roberto Faggiani, Costantino Zampaletta, Giorgio Pelecca, Giovanni Brandimarte. Managing ambulatory ulcerative colitis patients with infliximab: A long-term follow-up study in primary gastroenterology centersEuropean Journal of Internal Medicine 2014; 25(8): 757 doi: 10.1016/j.ejim.2014.07.007
14
Bence Kővári, Ágnes Báthori, Mark S. Friedman, Gregory Y. Lauwers. Histologic Diagnosis of Inflammatory Bowel DiseasesAdvances in Anatomic Pathology 2022; 29(1): 48 doi: 10.1097/PAP.0000000000000325
15
Emre Turer, William McAlpine, Kuan-wen Wang, Tianshi Lu, Xiaohong Li, Miao Tang, Xiaoming Zhan, Tao Wang, Xiaowei Zhan, Chun-Hui Bu, Anne R. Murray, Bruce Beutler. Creatine maintains intestinal homeostasis and protects against colitisProceedings of the National Academy of Sciences 2017; 114(7) doi: 10.1073/pnas.1621400114
16
R.V. Bryant, S. Winer, Travis SPL, R.H. Riddell. Systematic review: Histological remission in inflammatory bowel disease. Is ‘complete’ remission the new treatment paradigm? An IOIBD initiativeJournal of Crohn's and Colitis 2014; 8(12): 1582 doi: 10.1016/j.crohns.2014.08.011
17
Savini L. Santha, Prabhu R. Shankar, Anqi Pan, Bess Schoen, Subra Kugathasan, Cary G. Sauer. Mucosal Healing in Clinical PracticeInflammatory Bowel Diseases 2017; 23(8): 1447 doi: 10.1097/MIB.0000000000001176
18
Francesca Paola Giugliano, Caterina Strisciuglio, Massimo Martinelli, Marialuisa Andreozzi, Sabrina Cenni, Severo Campione, Maria D’Armiento, Annamaria Staiano, Erasmo Miele. Does Azathioprine induce endoscopic and histologic healing in pediatric inflammatory bowel disease? A prospective, observational studyDigestive and Liver Disease 2018; 50(3): 240 doi: 10.1016/j.dld.2017.10.017
19
Joshua Royal, Nobuyuki Matoba. Therapeutic Potential of Cholera Toxin B Subunit for the Treatment of Inflammatory Diseases of the MucosaToxins 2017; 9(12): 379 doi: 10.3390/toxins9120379
20
Jan Melek, Markéta Štanclová, Petr Dědek, Jan Malý, Milan Bayer, Oldřich Pozler, Jan Bureš. Infliximab plus azathioprine is more effective than azathioprine alone in achieving mucosal healing in pediatric patients with Crohn's diseaseJournal of Digestive Diseases 2020; 21(12): 705 doi: 10.1111/1751-2980.12927
21
Antonio Tursi, Walter Elisei, Marcello Picchio, Antonio Penna, Piera Giuseppina Lecca, Giacomo Forti, GianMarco Giorgetti, Roberto Faggiani, Costantino Zampaletta, Giorgio Pelecca, Giovanni Brandimarte. Effectiveness and safety of infliximab and adalimumab for ambulatory Crohn's disease patients in primary gastroenterology centresEuropean Journal of Internal Medicine 2014; 25(5): 485 doi: 10.1016/j.ejim.2014.02.010
22
Robert V Bryant, Oliver Brain, Simon P.L. Travis. Conventional drug therapy for inflammatory bowel diseaseScandinavian Journal of Gastroenterology 2015; 50(1): 90 doi: 10.3109/00365521.2014.968864
23
A. S. Tertychnyi, Kh. M. Akhrieva, I. V. Maev, O. V. Zayratyants, L. S. Selivanova. Diagnostic problems of histological remission in patients with inflammatory bowel diseaseArkhiv patologii 2017; 79(3): 3 doi: 10.17116/patol20177933-9
24
Sumit Sharma, Vivek R. Sinha. Current pharmaceutical strategies for efficient site specific delivery in inflamed distal intestinal mucosaJournal of Controlled Release 2018; 272: 97 doi: 10.1016/j.jconrel.2018.01.003
25
Neeraj Narula, Achuthan Aruljothy, Abdul‐Aziz Alshahrani, Ma’ayan Fadida, Mona Al‐Saedi, John K. Marshall, David T. Rubin, Britt Christensen. Histologic remission does not offer additional benefit for ulcerative colitis patients in endoscopic remissionAlimentary Pharmacology & Therapeutics 2020; 52(11-12): 1676 doi: 10.1111/apt.16147
26
Anna Wiernicka, Sylwia Szymanska, Joanna Cielecka-Kuszyk, Maciej Dadalski, Jaroslaw Kierkus. Histological healing after infliximab induction therapy in children with ulcerative colitisWorld Journal of Gastroenterology 2015; 21(37): 10654-10661 doi: 10.3748/wjg.v21.i37.10654
27
Sei Adachi, Hiroshi Arakawa, Seita Koyama, Keisuke Saito, Zensho Ito, Yoshihiro Matsumoto, Kazuki Takakura, Shintaro Tsukinaga, Shunichi Odahara, Toyokazu Yukawa, Mikio Kajihara, Kan Uchiyama, Shigeo Koido, Toshifumi Ohkusa, Hisao Tajiri. Correlation between endoscopic healing and histological healing of ulcerative colitis determined using the Mayo scoreProgress of Digestive Endoscopy 2014; 85(1): 43 doi: 10.11641/pde.85.1_43
28
Giovanna A. Belo, Bárbara F. Cordeiro, Emiliano R. Oliveira, Marina P. Braga, Sara H. da Silva, Bruno G. Costa, Flaviano dos S. Martins, Gwénaël Jan, Yves Le Loir, Alfonso Gala-García, Enio Ferreira, Vasco Azevedo, Fillipe L. R. do Carmo. SlpB Protein Enhances the Probiotic Potential of L. lactis NCDO 2118 in Colitis Mice ModelFrontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.755825
29
Javier Ampuero, María Rojas‐Feria, Manuel Castro‐Fernández, Marina Millán‐Lorenzo, Pedro Guerrero-Jiménez, Manuel Romero‐Gómez. Remission maintained by monotherapy after biological + immunosuppressive combination for Crohn's disease in clinical practiceJournal of Gastroenterology and Hepatology 2016; 31(1): 112 doi: 10.1111/jgh.13039
30
Fernando Magro, Susana Lopes, Marco Silva, Rosa Coelho, Francisco Portela, Diogo Branquinho, Luís Correia, Samuel Fernandes, Marília Cravo, Paulo Caldeira, Helena Tavares de Sousa, Marta Patita, Paula Lago, Jaime Ramos, Joana Afonso, Isabel Redondo, Patrícia Machado, George Philip, Joanne Lopes, Fátima Carneiro. Soluble human Suppression of Tumorigenicity 2 is associated with endoscopic activity in patients with moderate-to-severe ulcerative colitis treated with golimumabTherapeutic Advances in Gastroenterology 2019; 12: 175628481986914 doi: 10.1177/1756284819869141
31
Marion Lirsac, Amélie Biron, Zoubir Djerada, Guillaume Cadiot, Elise Morcos-Sauvain, Hedia Brixi, Margaux Le Saint, Aude Marchal, Camille Boulagnon-Rombi. Histological Indices and Risk of Recurrence in Crohn’s Disease: A Retrospective Study of a Cohort of Patients in Endoscopic RemissionInflammatory Bowel Diseases 2022; 28(9): 1395 doi: 10.1093/ibd/izac074
32
V. Villanacci, M. Salemme, G. Bassotti, E. Antonelli. Letter: histological assessment of disease activity in ulcerative colitis – the problem of score evaluation and validationAlimentary Pharmacology & Therapeutics 2016; 43(3): 438 doi: 10.1111/apt.13473
33
Haggai Bar-Yoseph, Alexandra Blatt, Shiran Gerassy, Sigal Pressman, Amjad Mousa, Edmond Sabo, Matti Waterman, Bella Ungar, Shomron Ben-Horin, Yehuda Chowers. Differential Serum-intestinal Dynamics of Infliximab and Adalimumab in Inflammatory Bowel Disease PatientsJournal of Crohn's and Colitis 2022; 16(6): 884 doi: 10.1093/ecco-jcc/jjab208
34
A. Marchal Bressenot, R. H. Riddell, C. Boulagnon-Rombi, W. Reinisch, S. Danese, S. Schreiber, L. Peyrin-Biroulet. Review article: the histological assessment of disease activity in ulcerative colitisAlimentary Pharmacology & Therapeutics 2015; 42(8): 957 doi: 10.1111/apt.13375
35
Mark Löwenberg, Severine Vermeire, Nahid Mostafavi, Frank Hoentjen, Denis Franchimont, Peter Bossuyt, Pieter Hindryckx, Theo Rispens, Annick de Vries, C. Janneke van der Woude, Sophie Berends, Carmen A. Ambarus, Ron Mathot, Esme Clasquin, Filip Baert, Geert D’Haens. Vedolizumab Induces Endoscopic and Histologic Remission in Patients With Crohn’s DiseaseGastroenterology 2019; 157(4): 997 doi: 10.1053/j.gastro.2019.05.067
36
Luca Scarallo, Patrizia Alvisi, Giulia Bolasco, Michele Di Toma, Marcello Lanari, Alice Cangiari, Monica Paci, Sara Naldini, Sara Renzo, Jacopo Barp, Salvatore De Masi, Paolo Lionetti. Mucosal and Histologic Healing in Children With Inflammatory Bowel Disease Treated With Antitumor Necrosis Factor-AlphaJournal of Pediatric Gastroenterology & Nutrition 2021; 72(5): 728 doi: 10.1097/MPG.0000000000003043
37
A. Caputo, P. Parente, M. Cadei, M. Fassan, A. Rispo, G. Leoncini, G. Bassotti, R. Del Sordo, C. Metelli, M. Daperno, A. Armuzzi, V. Villanacci. Simplified Histologic Mucosal Healing Scheme (SHMHS) for inflammatory bowel disease: a nationwide multicenter study of performance and applicabilityTechniques in Coloproctology 2022; 26(9): 713 doi: 10.1007/s10151-022-02628-7
38
G. Bassotti, E. Antonelli, V. Villanacci, R. Nascimbeni, M. P. Dore, G. M. Pes, G. Maconi. Abnormal gut motility in inflammatory bowel disease: an updateTechniques in Coloproctology 2020; 24(4): 275 doi: 10.1007/s10151-020-02168-y
39
Rish K. Pai, Geert D’Haens, Taku Kobayashi, Bruce E. Sands, Simon Travis, Vipul Jairath, Gert De Hertogh, Bomina Park, Kim McGinnis, Isabel Redondo, Nicole G. Lipitz, Theresa Hunter Gibble, Fernando Magro. Histologic assessments in ulcerative colitis: the evidence behind a new endpoint in clinical trialsExpert Review of Gastroenterology & Hepatology 2024; 18(1-3): 73 doi: 10.1080/17474124.2024.2326838
40
Pinelopi Nterma, Eleni Panopoulou, Eleni Papadaki-Petrou, Martha Assimakopoulou. Immunohistochemical Profile of Tumor Suppressor Proteins RASSF1A and LATS1/2 in Relation to p73 and YAP Expression, of Human Inflammatory Bowel Disease and Normal IntestinePathology & Oncology Research 2020; 26(1): 567 doi: 10.1007/s12253-018-00575-z
41
Olga Maria Nardone, Rosanna Cannatelli, Davide Zardo, Subrata Ghosh, Iacucci Marietta. Can advanced endoscopic techniques for assessment of mucosal inflammation and healing approximate histology in inflammatory bowel disease?Therapeutic Advances in Gastroenterology 2019; 12: 175628481986301 doi: 10.1177/1756284819863015
42
Marzia Lazzerini, Vincenzo Villanacci, Maria Chiara Pellegrin, Stefano Martelossi, Giuseppe Magazzù, Salvatore Pellegrino, Maria Cristina Lucanto, Arrigo Barabino, Angela Calvi, Serena Arrigo, Paolo Lionetti, Massimo Fontana, Giovanna Zuin, Giuseppe Maggiore, Matteo Bramuzzo, Massimo Maschio, Marianna Salemme, Stefania Manenti, Luisa Lorenzi, Giuliana Decorti, Marcella Montico, Alessandro Ventura. Endoscopic and Histologic Healing in Children With Inflammatory Bowel Diseases Treated With ThalidomideClinical Gastroenterology and Hepatology 2017; 15(9): 1382 doi: 10.1016/j.cgh.2017.02.029
43
Vincenzo Villanacci, Mattia Bugatti, Stefania Zini, Rachele Del Sordo, Gabrio Bassotti. Letter: The importance of histological assessment—a further stride in STRIDEAlimentary Pharmacology & Therapeutics 2023; 58(11-12): 1244 doi: 10.1111/apt.17717
44
Weiming Lai, Changxiu Xian, Mingxia Chen, Ding Luo, Junxia Zheng, Suqing Zhao, Xiang-Guang Li. Single-cell and bulk transcriptomics reveals M2d macrophages as a potential therapeutic strategy for mucosal healing in ulcerative colitisInternational Immunopharmacology 2023; 121: 110509 doi: 10.1016/j.intimp.2023.110509
45
Elisabetta Antonelli, Vincenzo Villanacci, Gabrio Bassotti. Novel oral-targeted therapies for mucosal healing in ulcerative colitisWorld Journal of Gastroenterology 2018; 24(47): 5322-5330 doi: 10.3748/wjg.v24.i47.5322
46
Jesse Kresak, Bo Shen, Xiuli Liu. Atlas of Endoscopy Imaging in Inflammatory Bowel Disease2020; : 525 doi: 10.1016/B978-0-12-814811-2.00034-7
47
Min-Jin Kwak, Dong-Jin Ha, Yong-Soon Choi, Hanbae Lee, Kwang-Youn Whang. Protective and restorative effects of sophorolipid on intestinal dystrophy in dextran sulfate sodium-induced colitis mouse modelFood & Function 2022; 13(1): 161 doi: 10.1039/D1FO03109K
48
Karel Geboes, Maria Leo, Daniela Fanni, Gavino Faa. Colitis2014; : 93 doi: 10.1007/978-3-319-08028-4_6
49
Yaron Niv, Eyal Gal, Violeta Gabovitz, Marcela Hershkovitz, Lev Lichtenstein, Irit Avni. Capsule Endoscopy Crohn’s Disease Activity Index (CECDAIic or Niv Score) for the Small Bowel and ColonJournal of Clinical Gastroenterology 2018; 52(1): 45 doi: 10.1097/MCG.0000000000000720
50
Peter Bossuyt, Raf Bisschops, Séverine Vermeire, Gert De Hertogh. Variability in the Distribution of Histological Disease Activity in the Colon of Patients with Ulcerative ColitisJournal of Crohn's and Colitis 2021; 15(4): 603 doi: 10.1093/ecco-jcc/jjaa206
51
Ruoxi Zhang, Chunhua Yu, Herbert J. Zeh, Haichao Wang, Guido Kroemer, Daniel J. Klionsky, Timothy R. Billiar, Rui Kang, Daolin Tang. Nuclear localization of STING1 competes with canonical signaling to activate AHR for commensal and intestinal homeostasisImmunity 2023; 56(12): 2736 doi: 10.1016/j.immuni.2023.11.001
52
Misagh Alipour, Deenaz Zaidi, Rosica Valcheva, Juan Jovel, Inés Martínez, Consolato Sergi, Jens Walter, Andrew L. Mason, Gane Ka-Shu Wong, Levinus A. Dieleman, Matthew W. Carroll, Hien Q. Huynh, Eytan Wine. Mucosal Barrier Depletion and Loss of Bacterial Diversity are Primary Abnormalities in Paediatric Ulcerative ColitisJournal of Crohn's and Colitis 2016; 10(4): 462 doi: 10.1093/ecco-jcc/jjv223
53
Parambir S. Dulai, Barrett G. Levesque, Brian G. Feagan, Geert D’Haens, William J. Sandborn. Assessment of mucosal healing in inflammatory bowel disease: reviewGastrointestinal Endoscopy 2015; 82(2): 246 doi: 10.1016/j.gie.2015.03.1974
54
Alexander Rodriguez-Palacios, Fabio Cominelli. Crohn’s Disease–Like Ileitis and the Inhibitory Effect of Sucralose on StreptococciInflammatory Bowel Diseases 2019; 25(4): e34 doi: 10.1093/ibd/izy251
55
Elisabetta Antonelli, Gabriele Torti, Gabrio Bassotti. Inhibitors of the Janus KinasesJournal of Clinical Gastroenterology 2019; 53(9): 635 doi: 10.1097/MCG.0000000000001250
56
Silvia Mazzuoli, Francesco W. Guglielmi, Elisabetta Antonelli, Marianna Salemme, Gabrio Bassotti, Vincenzo Villanacci. Definition and evaluation of mucosal healing in clinical practiceDigestive and Liver Disease 2013; 45(12): 969 doi: 10.1016/j.dld.2013.06.010
57
Luca Scarallo, Lorenzo Fioretti, Monica Paci, Sara Naldini, Sara Renzo, Jacopo Barp, Anna Gissi, Monica Di Paola, Vincenzo Villanacci, Paolo Lionetti. Histological healing as a predictor of sustained clinical remission in paediatric ulcerative colitisDigestive and Liver Disease 2024; 56(1): 43 doi: 10.1016/j.dld.2023.06.020
58
Christopher G. Chapman, Vani J.A. Konda. Confocal laser endomicroscopy in inflammatory bowel disease: achieving new depths in mucosal healingGastrointestinal Endoscopy 2016; 83(4): 792 doi: 10.1016/j.gie.2015.11.002
59
Vincenzo Villanacci, Elisabetta Antonelli, Francesco Lanzarotto, Anna Bozzola, Moris Cadei, Gabrio Bassotti. Usefulness of Different Pathological Scores to Assess Healing of the Mucosa in Inflammatory Bowel Diseases: A Real Life StudyScientific Reports 2017; 7(1) doi: 10.1038/s41598-017-07338-x
60
José R. Cruz-Muñoz, Tonatiuh Barrios-García, Eduardo E. Valdez-Morales, María F. Durán-Vazquez, Karen B. Méndez-Rodríguez, Alma Barajas-Espinosa, Fernando Ochoa-Cortes, María C. Martínez-Saldaña, Yenny A. Gómez-Aguirre, Raquel Guerrero Alba. Ethanolic extract from Lepidium virginicum L. ameliorates DNBS-induced colitis in ratsJournal of Ethnopharmacology 2022; 289: 115056 doi: 10.1016/j.jep.2022.115056
61
Rodrigo Papa Gobbi, Nicolás De Francesco, Constanza Bondar, Cecilia Muglia, Fernando Chirdo, Martín Rumbo, Andrés Rocca, Marta A. Toscano, Alicia Sambuelli, Gabriel A. Rabinovich, Guillermo H. Docena. A galectin‐specific signature in the gut delineates Crohn's disease and ulcerative colitis from other human inflammatory intestinal disordersBioFactors 2016; 42(1): 93 doi: 10.1002/biof.1252
62
Karel Geboes, Olivier Dewit, Tom G. Moreels, Gavino Faa, Anne Jouret-Mourin. Colitis2018; : 107 doi: 10.1007/978-3-319-89503-1_8
63
Joshua M. Royal, Young Jun Oh, Michael J. Grey, Wayne I. Lencer, Nemencio Ronquillo, Susan Galandiuk, Nobuyuki Matoba. A modified cholera toxin B subunit containing an ER retention motif enhances colon epithelial repair via an unfolded protein responseThe FASEB Journal 2019; 33(12): 13527 doi: 10.1096/fj.201901255R
64
Cristiana Popp, Radu Bogdan Mateescu. New Concepts in Inflammatory Bowel Disease2018;  doi: 10.5772/intechopen.72893
65
BO Ajayi, IA Adedara, EO Farombi. Protective mechanisms of 6-gingerol in dextran sulfate sodium-induced chronic ulcerative colitis in miceHuman & Experimental Toxicology 2018; 37(10): 1054 doi: 10.1177/0960327117751235
66
Elham Aghamohamadi, Nastaran Asri †, Aylin Odak, Mohammad Rostami-Nejad, Vahid Chaleshi, Yasaman Hajinabi, Maryam Eslami, Saeed Mohammadian Haftcheshmeh, Fahimeh Sadat Gholam-Mostafaei, Hamid Asadzadeh-Aghdaei, Andrea Masotti, Mohammad Reza Zali. Gene expression analysis of intestinal IL-8, IL-17 A and IL-10 in patients with celiac and inflammatory bowel diseasesMolecular Biology Reports 2022; 49(7): 6085 doi: 10.1007/s11033-022-07397-y
67
Kelsey G. DeFrates, Elaine Tong, Jing Cheng, Ellen Heber‐Katz, Phillip B. Messersmith. A Pro‐Regenerative Supramolecular Prodrug Protects Against and Repairs Colon Damage in Experimental ColitisAdvanced Science 2024;  doi: 10.1002/advs.202304716
68
Camille Boulagnon-Rombi, Aude Marchal, Marion Lirsac, Magali Svrcek. Maladies inflammatoires chroniques intestinales : scores et optimisation des comptes rendus anatomopathologiquesAnnales de Pathologie 2023; 43(3): 170 doi: 10.1016/j.annpat.2023.03.007
69
Antonio Tursi, Walter Elisei, Marcello Picchio, Giacomo Forti, Antonio Penna, Cosimo Damiano Inchingolo, Rosanna Nenna, Giovanni Brandimarte. Histological inflammation in ulcerative colitis in deep remission under treatment with infliximabClinics and Research in Hepatology and Gastroenterology 2015; 39(1): 107 doi: 10.1016/j.clinre.2014.07.012
70
Tessa E H Römkens, Pim Kranenburg, Arjan van Tilburg, Carolien Bronkhorst, Iris D Nagtegaal, Joost P H Drenth, Frank Hoentjen. Assessment of Histological Remission in Ulcerative Colitis: Discrepancies Between Daily Practice and Expert OpinionJournal of Crohn's and Colitis 2018; 12(4): 425 doi: 10.1093/ecco-jcc/jjx165
71
Dwight A. Winter, Maria E. Joosse, Saskia N. de Wildt, Jan Taminiau, Lissy de Ridder, Johanna C. Escher. Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Infliximab in Pediatric Inflammatory Bowel DiseaseJournal of Pediatric Gastroenterology and Nutrition 2020; 70(6): 763 doi: 10.1097/MPG.0000000000002631
72
Laurent Peyrin-Biroulet, Edward V. Loftus, Jean-Frédéric Colombel, Silvio Danese, Raquel Rogers, Jeffrey D. Bornstein, Jingjing Chen, Stefan Schreiber, Bruce E. Sands, Richard A. Lirio. Histologic Outcomes With Vedolizumab Versus Adalimumab in Ulcerative Colitis: Results From An Efficacy and Safety Study of Vedolizumab Intravenous Compared to Adalimumab Subcutaneous in Participants With Ulcerative Colitis (VARSITY)Gastroenterology 2021; 161(4): 1156 doi: 10.1053/j.gastro.2021.06.015
73
Rodrigo Papa-Gobbi, Cecilia I. Muglia, Andrés Rocca, Renata Curciarello, Alicia M. Sambuelli, Martín Yantorno, Gustavo Correa, Luciano G. Morosi, Antonio Di Sabatino, Paolo Biancheri, Thomas T. MacDonald, Marta A. Toscano, Karina V. Mariño, Gabriel A. Rabinovich, Guillermo H. Docena. Spatiotemporal regulation of galectin-1-induced T-cell death in lamina propria from Crohn’s disease and ulcerative colitis patientsApoptosis 2021; 26(5-6): 323 doi: 10.1007/s10495-021-01675-z
74
You Yeon Choi, Ki Moon Seong, Hyun Jung Lee, Seung Sook Lee, Areumnuri Kim. RETRACTED ARTICLE: Expansion of monocytic myeloid-derived suppressor cells ameliorated intestinal inflammatory response by radiation through SOCS3 expressionCell Death & Disease 2021; 12(9) doi: 10.1038/s41419-021-04103-x
75
Peter Bossuyt, Séverine Vermeire. Treat to Target in Inflammatory Bowel DiseaseCurrent Treatment Options in Gastroenterology 2016; 14(1): 61 doi: 10.1007/s11938-016-0077-z
76
Stephanie N. Spohn, Francesca Bianco, Rachel B. Scott, Catherine M. Keenan, Alisha A. Linton, Conor H. O'Neill, Elena Bonora, Michael Dicay, Brigitte Lavoie, Rebecca L. Wilcox, Wallace K. MacNaughton, Roberto De Giorgio, Keith A. Sharkey, Gary M. Mawe. Protective Actions of Epithelial 5-Hydroxytryptamine 4 Receptors in Normal and Inflamed ColonGastroenterology 2016; 151(5): 933 doi: 10.1053/j.gastro.2016.07.032